Return
Step 1/10

Participate in the ENLIGHTEN-3 study

XX$ compensation

ENLIGHTEN-3 is a new clinical research study from Eli Lilly and Company. It aims to test whether an experimental drug (a drug under study) can help treat people with obesity or overweight and obstructive sleep apnea.
ReturnSign up

ELIGIBILITY CRITERIA

You may be eligible for this study if you meet all of the conditions set out in the following steps. Please answer “Yes” or “No” to each of the criteria.

ReturnContinue

Please indicate if you meet the following eligibility criteria: I am 18 years of age or older

ReturnContinue

Please indicate if you meet the following eligibility criteria: I have moderate to severe obstructive sleep apnea

ReturnContinue

Please indicate if you meet the following eligibility criteria: I have a body mass index greater than or equal to 27

ReturnContinue

Please indicate if you meet the following eligibility criteria: I have not lost or gained 5% of my body weight or more in the last 3 months

ReturnContinue

Please indicate if you meet the following eligibility criteria: At one point, I tried to lose weight by changing my eating habits, without success

ReturnContinue

Please indicate if you meet the following eligibility criteria: I am not diabetic

ReturnContinue

Let's finish with your contact details

Return
Merci ! Nous avons bien reçu votre inscription. Un agent vous contactera dès que possible.
Make an appointment
Whoops! An error occurred while submitting the form.
© xxxx Côté Santé Group Inc. All rights reserved.
Confidentiality policyTerms of use

Do you suffer from obesity or excess weight and obstructive sleep apnea?

Any questions?
Details of the study
The details

Compensation of $XX offered

Polysomnography at weeks 6, 16 and 64

Collection of CPAP Masks on Shelf

By clicking on "Accept", you agree to cookies being stored on your device in order to improve site navigation. See our privacy policy for more information.

AcceptPersonnalize